6:00 - 7:00 pm
Reception to follow
415 Main Street, Cambridge, MA
The time and cost of whole genome sequencing has dropped so much over the last 20 years that it could soon be part of everyone's medical care. What could that mean for the future of our health? Come join institute scientist and Broad Clinical Labs CSO Niall Lennon for a conversation about what the intersection of medical genomics, precision medicine, and preventive healthcare could mean for you.
This free talk is open to members of the general public and is appropriate for high school students and beyond.
Speaker
Niall Lennon
Niall Lennon is the senior director of the Genomics Platform, an associate director of the Gerstner Center for Cancer Diagnostics, and an institute scientist at the Broad Institute. He is also the chief scientific officer and chair of the board of Broad Clinical Laboratories, a wholly owned subsidiary of the institute. He oversees the development, implementation, validation, and operation of disruptive technologies and analytical methods to serve research, clinical research, and clinical diagnostics across a range of fields from infectious disease and cancer to rare and chronic diseases.
The Broad Discovery Series brings researchers to the stage to discuss and answer questions about some of the most pressing topics in science and medicine today. Held in-person and virtually at the Broad Institute of MIT and Harvard, these free public events explore the genetic and biological roots of human health and disease, the mechanisms that govern how our cells and bodies function, new technologies that are changing what's possible in science, and the progress being made to translate these findings into treatments for common and rare diseases.
Please visit broad.io/DiscoveryLive to access the event live stream at the time of the event.